Redeye trims its forecast following Q3’26 figures, which posted healthy progress although somewhat below expectations. The underlying business continues to perform well, while the near-term EU-BPR seems to scare the market more than necessary. We remain positive on the share, which has become increasingly attractive as a negative outcome in the EU has been the most likely scenario for quite some time.
LÄS MER
